Olema Pharmaceuticals (OLMA) CEO Bohen received 650,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Sean Bohen (President and CEO at Olema Pharmaceuticals Inc., OLMA) reported that they received 650,000 Stock Option (Right to Buy) on Feb 28, 2025.
- Reporting person
- Bohen Sean
- Role
- PRESIDENT AND CEO
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | Grant or award (A) | Stock Option (Right to Buy)On 650,000 Common Stock1 | +650,000 | - | - | 650,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 650,000 direct
Footnotes from the filing
- 1. 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Bohen report in this OLMA Form 4?
Sean Bohen (President and CEO at Olema Pharmaceuticals Inc., OLMA) reported that they received 650,000 Stock Option (Right to Buy) on Feb 28, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for OLMA
Earlier insider filings at OLMA
- Jan 14, 2025See Explanation of Responses Bvf Partners L P/Il returned 420,000 shares to the company (SEC Form 4)
- Jan 13, 2025Large owner Bain Capital Life Sciences Investors, Llc bought $1,727,370 worth of shares (300,000 units at $5.76) and disposed of 3,500,000 shares (SEC Form 4)
- Dec 18, 2024Amendment: Director Graham G. Walmsley sold $4,730,137 worth of shares (700,761 units at $6.75) and bought $4,730,137 worth of shares (700,761 units at $6.75) (SEC Form 4)
- Dec 18, 2024Director Graham G. Walmsley sold $4,730,137 worth of shares (700,761 units at $6.75) (SEC Form 4)
- Dec 18, 2024CHIEF MEDICAL OFFICER Zojwalla Naseem exercised 14,000 shares at a strike of $4.87, increasing direct ownership by 12% to 129,509 units (SEC Form 4)
Quantisnow market dataNASDAQ
OLMA
Olema Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for OLMA
Full OLMA profile on Quantisnow Follow OLMA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time